The use of azathiaprine and 6-mercaptopurine (6-MP) as immunosuppressive therapy in inflammatory bowel disease and its role in the etiology of lymphocytic lymphoma.
D001379:Azathioprine / Q000009:adverse effects*; D003092:Colitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced*; D015122:Mercaptopurine / Q000009:adverse effects*; D008875:Middle Aged
D015122:Mercaptopurine; D001379:Azathioprine